Stay updated with breaking news from Nasdaq Bctx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BriaCell Therapeutics Corp. (NASDAQ:BCTX – Get Rating)’s stock price dropped 4.6% on Wednesday . The company traded as low as $5.95 and last traded at $6.03. Approximately 101,680 shares were traded during trading, a decline of 44% from the average daily volume of 181,220 shares. The stock had previously closed at $6.32. Wall Street Analysts […]
BriaCell Therapeutics Corp. (NASDAQ:BCTX – Get Rating) – Research analysts at Zacks Small Cap decreased their FY2023 earnings per share (EPS) estimates for shares of BriaCell Therapeutics in a research report issued on Thursday, April 27th. Zacks Small Cap analyst J. Vandermosten now forecasts that the company will earn ($1.57) per share for the year, […]
BriaCell Therapeutics Corp. (NASDAQ:BCTX – Get Rating) was the target of a significant decrease in short interest in March. As of March 15th, there was short interest totalling 1,500,000 shares, a decrease of 6.3% from the February 28th total of 1,600,000 shares. Approximately 14.6% of the company’s stock are short sold. Based on an average […]
Wall Street brokerages predict that BriaCell Therapeutics Corp. (NASDAQ:BCTX – Get Rating) will post ($0.19) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have made estimates for BriaCell Therapeutics’ earnings. The highest EPS estimate is ($0.17) and the lowest is ($0.21). BriaCell Therapeutics posted earnings of ($0.93) per […]
Concord Wealth Partners bought a new position in BriaCell Therapeutics Corp. (NASDAQ:BCTX – Get Rating) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 12,775 shares of the company’s stock, valued at approximately $106,000. Concord Wealth Partners owned about 0.08% of BriaCell Therapeutics […]